Cancer Therapy News and Research

RSS

Stereotactic radiosurgery improves survival in adult brain cancer patients under 50

When treated with stereotactic radiosurgery, that is not combined with whole brain radiotherapy, adult brain cancer patients who were 50 years old and younger were found to have improved survival, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

The American Society for Radiation Oncology will highlight the recently published Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline during ASTRO's 55th Annual Meeting, September 22-25, 2013, in Atlanta.

24 Sep 2013

Lung cancer patients who received IMRT report less decline in their QOL

An analysis of quality of life (QOL) data of stage III lung cancer patients who received higher doses of radiation therapy (with chemotherapy) shows a significantly lower quality of life at 3 months after treatment compared to patients who received a standard dose of radiation (with chemotherapy), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

24 Sep 2013

Marriage improves outcomes among patients with cancer, says oncologist

New results from a large retrospective study of the National Cancer Institute's SEER database show that patients with cancer who were married at the time of diagnosis live markedly longer compared to unmarried patients.

24 Sep 2013

Older women with newly diagnosed breast cancer are more likely to experience functional disability

Many older women with newly diagnosed breast cancer have difficulty accomplishing daily tasks, and African-Americans seem to be disproportionately affected.

23 Sep 2013

Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers.

20 Sep 2013

ASTRO to honor Atlanta resident and cancer survivor with 2013 Survivor Circle Award

The American Society for Radiation Oncology has selected Atlanta resident and cancer survivor Sherri Graves Smith to receive the 2013 Survivor Circle Award.

19 Sep 2013

Overactivity of EGFR protein leads to heightened cancer growth and chemotherapy resistance

Overactivity of a protein that normally cues cells to divide sabotages the body-s natural cellular recycling process, leading to heightened cancer growth and chemotherapy resistance, UT Southwestern Medical Center researchers have found.

19 Sep 2013

Different types of narratives have different effects on patients' health decision-making processes

Individuals often turn to others for advice when making choices. Perhaps, it seems fitting then, that individuals would seek out others when they are faced with important health decisions.

19 Sep 2013

New gonorrhea treatment eliminates gonococcal infection from female mice

A new gonorrhea treatment, based on an anti-cancer therapy developed by a Buffalo startup company, has successfully eliminated gonococcal infection from female mice and prevented reinfection, according to research published today by University at Buffalo scientists in the Journal of Infectious Diseases.

19 Sep 2013

ASTRO to award $8,000 Survivor Circle grants to two Georgia cancer patient support groups

The American Society for Radiation Oncology (ASTRO) has selected two Georgia cancer patient support groups, The Cancer Foundation of Northeast Georgia and the South Georgia Medical Center, Pearlman Cancer Center, to receive ASTRO's 2013 Survivor Circle grants.

19 Sep 2013

Drug used in patients for cancer treatment has beneficial effects on diabetes

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.

16 Sep 2013

Tips for parents of children with cancer

September is Childhood Cancer Awareness Month, and Lisa Diller, MD, chief medical officer of Dana-Farber/Boston Children's Cancer and Blood Disorders Center, advises parents to remain positive if their child is among the 12,000 children in the United States diagnosed with cancer each year.

13 Sep 2013

Data can help scientists, physicians match precision drugs to cancer's genetic traits

More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.

13 Sep 2013

New study to reduce unwanted side-effects of radiotherapy

Scientists from The University of Manchester are leading a new European study to come up with methods to reduce the unwanted side-effects of radiotherapy and improve cancer treatment.

From The University of Manchester 12 Sep 2013

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.

12 Sep 2013

Personalized treatment may be effective in wild type cancers

As a woman in her mid-forties who didn't smoke, Elizabeth Lacasia never expected to be diagnosed with lung cancer. But in 2006, after she developed a persistent and serious cough, a chest X-ray and CT scan revealed several tumors in her lower left lung.

11 Sep 2013

Research finding could lead to better solutions for cancer, anti-viral treatments

Medical scientists at the University of Alberta have made a key discovery about how the immune system kills healthy cells while attacking infections. This finding could one day lead to better solutions for cancer and anti-viral treatments.

11 Sep 2013

Discovery opens doors for developing new therapies to eradicate tumor cells, combat infections

Scientists from A*STAR's Singapore Immunology Network have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells.

11 Sep 2013

Astrazeneca, Hadasit Launch Drug Discovery Alliance

...

10 Sep 2013

Cancer Therapy News and Research

Stereotactic radiosurgery improves survival in adult brain cancer patients under 50

Guideline focuses on radiation therapy to be highlighted during ASTRO's 55th Annual Meeting

Lung cancer patients who received IMRT report less decline in their QOL

Marriage improves outcomes among patients with cancer, says oncologist

Older women with newly diagnosed breast cancer are more likely to experience functional disability

Researchers discover new mechanism involving p53 to fight against aggressive cancers

ASTRO to honor Atlanta resident and cancer survivor with 2013 Survivor Circle Award

Overactivity of EGFR protein leads to heightened cancer growth and chemotherapy resistance

Different types of narratives have different effects on patients' health decision-making processes

New gonorrhea treatment eliminates gonococcal infection from female mice

ASTRO to award $8,000 Survivor Circle grants to two Georgia cancer patient support groups

Drug used in patients for cancer treatment has beneficial effects on diabetes

Tips for parents of children with cancer

Data can help scientists, physicians match precision drugs to cancer's genetic traits

New study to reduce unwanted side-effects of radiotherapy

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Personalized treatment may be effective in wild type cancers

Research finding could lead to better solutions for cancer, anti-viral treatments

Discovery opens doors for developing new therapies to eradicate tumor cells, combat infections

Astrazeneca, Hadasit Launch Drug Discovery Alliance

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News